Key Points
- Intuitive Surgical EVP Myriam Curet sold 126 shares on Jan. 29 at an average price of $520.02 for $65,522.52 and has made multiple recent insider sales (230 shares on Jan. 27 at $532.61; 104 on Dec. 10 at $559.90; 105 on Nov. 10 at $560.00).
- The company beat quarterly expectations, reporting EPS of $2.53 vs. $2.27 expected and revenue of $2.87 billion vs. $2.72 billion, with revenue up 18.8% year‑over‑year.
- Analysts are broadly positive, with a consensus rating of "Moderate Buy" and a consensus price target of $620.41, and several firms raising targets (Wells Fargo to $654, RBC to $650).
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Myriam Curet sold 126 shares of the stock in a transaction that occurred on Thursday, January 29th. The stock was sold at an average price of $520.02, for a total transaction of $65,522.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Myriam Curet also recently made the following trade(s):
- On Tuesday, January 27th, Myriam Curet sold 230 shares of Intuitive Surgical stock. The stock was sold at an average price of $532.61, for a total value of $122,500.30.
- On Wednesday, December 10th, Myriam Curet sold 104 shares of Intuitive Surgical stock. The stock was sold at an average price of $559.90, for a total transaction of $58,229.60.
- On Monday, November 10th, Myriam Curet sold 105 shares of Intuitive Surgical stock. The stock was sold at an average price of $560.00, for a total value of $58,800.00.
Intuitive Surgical Stock Performance
Shares of ISRG opened at $504.22 on Friday. The company's fifty day moving average is $558.64 and its 200 day moving average is $511.63. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $609.08. The stock has a market capitalization of $180.75 billion, a PE ratio of 63.91, a P/E/G ratio of 3.92 and a beta of 1.67.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company's revenue for the quarter was up 18.8% on a year-over-year basis. During the same period last year, the company earned $2.21 EPS. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.
Institutional Investors Weigh In On Intuitive Surgical
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. Vanguard Group Inc. increased its holdings in Intuitive Surgical by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider's stock worth $15,026,776,000 after buying an additional 263,828 shares during the period. State Street Corp boosted its holdings in shares of Intuitive Surgical by 1.2% in the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider's stock valued at $8,451,223,000 after acquiring an additional 182,871 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 1.4% in the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider's stock valued at $4,429,590,000 after acquiring an additional 109,904 shares during the last quarter. Capital World Investors increased its stake in shares of Intuitive Surgical by 1.5% in the third quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider's stock worth $3,456,223,000 after acquiring an additional 116,034 shares during the period. Finally, Norges Bank purchased a new position in shares of Intuitive Surgical during the second quarter worth $2,569,260,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on the stock. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an "overweight" rating in a report on Friday, December 12th. Royal Bank Of Canada lifted their price target on shares of Intuitive Surgical from $625.00 to $650.00 and gave the company an "outperform" rating in a research note on Wednesday, December 17th. Daiwa Capital Markets boosted their price target on Intuitive Surgical from $510.00 to $550.00 and gave the company an "outperform" rating in a report on Friday, October 24th. Weiss Ratings restated a "hold (c+)" rating on shares of Intuitive Surgical in a report on Monday, December 29th. Finally, Hsbc Global Res raised Intuitive Surgical to a "strong-buy" rating in a research report on Thursday, October 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $620.41.
Get Our Latest Stock Analysis on Intuitive Surgical
Intuitive Surgical Company Profile
(
Get Free Report)
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
